Literature DB >> 24746851

A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies.

Dany Spaggiari1, Laurent Geiser1, Youssef Daali1, Serge Rudaz2.   

Abstract

An assessment of cytochrome P450 (CYP) enzyme activity is essential for characterizing the phase I metabolism of biological systems or to evaluate the inhibition/induction properties of xenobiotics. CYPs have generally been investigated individually by single probes, and metabolite formation has been monitored by liquid chromatography-mass spectrometry (LC-MS). To increase the throughput, many probes have been applied to assess multiple CYP activities simultaneously within a single experiment. This strategy is called the cocktail approach, and it has already been reviewed for in vivo applications, but never for in vitro ones. This review focuses for the first time on an in vitro cocktail approach, and it references the most notable articles on this topic. The advantages and limitations of applying cocktails for the in vitro activity assessment of major human CYPs, namely, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and subfamily CYP3A, are discussed. This article considers the probe reaction selections for each CYP according to regulatory recommendations, probe metabolic properties (i.e., specificity and turnover), probe concentrations and analytical sensitivity, but it also highlights a challenge specific to cocktail design, which is probe-probe interaction. The last part of the review reports some methodologies for incubating these cocktails and discusses some important issues regarding the incubation time, enzyme concentrations and sample preparation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CYP phenotyping; Cocktail; Drug–drug interactions; Human liver microsomes; In vitro methodology

Mesh:

Substances:

Year:  2014        PMID: 24746851     DOI: 10.1016/j.jpba.2014.03.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  18 in total

1.  High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions.

Authors:  Guannan Li; Ke Huang; Dejan Nikolic; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2015-08-18       Impact factor: 3.922

2.  Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Xenobiotica       Date:  2020-07-26       Impact factor: 1.908

3.  CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Authors:  Mary Alexandra Schleiff; Samantha Crosby; Madison Blue; Benjamin Mark Schleiff; Gunnar Boysen; Grover Paul Miller
Journal:  Biochem Pharmacol       Date:  2021-11-05       Impact factor: 5.858

4.  Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.

Authors:  Jing Sun; Xiaozhu Tang; Qianqian Xu; Tao Ge; Daiyin Peng; Weidong Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

5.  Case Study 9: Probe-Dependent Binding Explains Lack of CYP2C9 Inactivation by 1-Aminobenzotriazole (ABT).

Authors:  Jasleen K Sodhi; Jason S Halladay
Journal:  Methods Mol Biol       Date:  2021

6.  Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats.

Authors:  Li Liu; Ming-xing Miao; Ze-yu Zhong; Ping Xu; Yang Chen; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

7.  Artificial neural network cascade identifies multi-P450 inhibitors in natural compounds.

Authors:  Zhangming Li; Yan Li; Lu Sun; Yun Tang; Lanru Liu; Wenliang Zhu
Journal:  PeerJ       Date:  2015-12-21       Impact factor: 2.984

8.  Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS/MS and cocktail approach.

Authors:  Ang Chen; Xiaojing Zhou; Shuowen Tang; Mingyao Liu; Xin Wang
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

9.  Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail.

Authors:  Benjamin Berger; Massimiliano Donzelli; Swarna Maseneni; Franziska Boess; Adrian Roth; Stephan Krähenbühl; Manuel Haschke
Journal:  Front Pharmacol       Date:  2016-11-21       Impact factor: 5.810

10.  The effect of ZnO nanoparticles on liver function in rats.

Authors:  Hua-Qiao Tang; Min Xu; Qian Rong; Ru-Wen Jin; Qi-Ji Liu; Ying-Lun Li
Journal:  Int J Nanomedicine       Date:  2016-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.